Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SPOCK1 contributors: mct/npt - updated : 07-07-2008
HGNC name sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
HGNC id 11251
DNA
TYPE functioning gene
STRUCTURE 524.00 kb     10 Exon(s)
MAPPING cloned Y linked N status confirmed
Map see IRF1
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
10 - 4841 49 439 - Prenzel (2006)
EXPRESSION
Type widely
constitutive of
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Hearing/Equilibriumear   highly
Nervousbrain   highly
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Connectiveadipose  highly
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • CWCV and Kazal-like domains proteoglycan
  • osteonectin (SPARC)-like domain
  • thyroglobuline type 1 repeat
  • HOMOLOGY
    interspecies homolog to murine Spock1
    Homologene
    FAMILY
  • testican family proteins
  • CATEGORY adhesion , regulatory
    SUBCELLULAR LOCALIZATION extracellular
    basic FUNCTION
  • multifunctional matricellular protein involved in cell-matrix interactions and might be involved in tumor pathogenesis and progression
  • may have a function related to protease inhibition in the blood
  • CELLULAR PROCESS cell life, proliferation/growth
    PHYSIOLOGICAL PROCESS
    text control of cell proliferation
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    overexpression is significantly more frequent in pancreatic cancer than cancer of the papilla of Vater
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS